Global Radiotherapy Technologies and Markets 2016-2021 - Major Players are Varian, Elekta, IBA-Worldwide Proton Therapy and Accuray
DUBLIN, July 24, 2017 /PRNewswire/ --
The "Radiotherapy: Technologies and Global Markets" report has been added to Research and Markets' offering.
The Global Radiotherapy Market Was Valued at $6.4 Billion in 2016. the Market Should Reach $6.8 Billion And $9.2 Billion in 2017 And 2022, Respectively; Growing at a CAGR of 6.4% from 2017 to 2022
The goal for this study was to determine the global market and future demand growth for radiation therapy equipment over a five-year period from 2017 to 2022.
With advances in technology and the advent of new software, the radiation therapy market is expected to increase during the forecasting period. New techniques have changed the way treatments are planned and doses are delivered. The use of radiation therapy is expected to increase as the incidence of cancer increases. The greatest growth in radiation therapy will be driven by demand in developing countries, particularly India and China.
We also evaluate the three types of radiotherapy, which are external radio therapy, internal radio therapy and systemic radiation therapy. Also opportunities in each type of radiation therapy market have been discussed in detail. Factors that affect each subsegment, the drivers, restraints, threat and opportunities, have been discussed. Our key objective was to present a comprehensive discussion of where the state-of-the-art is in radiation therapy and forecast the future commercial potential for the key market segments.
This discussion will provide a basis for companies to make strategic choices about developing new products and markets, or employing radiation therapy for treating cancer and other diseases. The study will benefit radiation therapy and radioactive substance manufacturers, users of radio therapy, medical instrument companies, life sciences tools companies, diagnostic and drug manufacturers, biotechnology companies, and developers of nanotechnologies.
The global external beam radiation therapy market was valued at $5.2 billion in 2016. The market should reach $5.5 billion and $7.5 billion in 2017 and 2022, respectively; at a CAGR of 6.4% from 2017 to 2022.
The global systemic radiation therapy market was valued at $570 million in 2016. The market should reach $665 million and $1.0 billion in 2017 and 2022, respectively; at a CAGR of 8.7% from 2017 to 2022.
Major market players include Varian (U.S), Elekta (Sweden), IBA-Worldwide Proton Therapy (Belgium), and Accuray (U.S.).
Key Topics Covered:
Chapter 1: Introduction
- Study Goals and Objectives
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Analyst's Credentials
- Related Research Reports
Chapter 2: Summary and Highlights
Chapter 3: Market and Technology Background
- Introduction to Cancer
- Definition
- Benign Tumors
- Malignant Tumors
- Other Types of Cancers
- Causes of Cancer
- Cancer Protective Factors and Risk Factors
- Introduction to Radiation
- Non-Ionizing Radiation
- Ionizing Radiation
- Particle Radiation
- History of Radiation Therapy
- The Discovery Period
- Kilovoltage Era (1900-1940)
- Megavoltage Era (1946-1996)
- Computer-assisted Era (1996-2017)
- Mechanism of Action
- Cell Growth Cycle
- Risk Management and Quality Assurance in Radiation Therapy
- Radiation Therapy Market Segmentation
- Drivers, Restraints, Opportunities and Trends
- Threat
- Market Share Analysis
- Different Cancer Treatments
Chapter 4: Market Breakdown by Product Type
- Introduction
- External Beam Radiation Therapy
- Treatment Planning for External Beam Radiation
- Electron-Emitting High-Energy Linear Accelerators (LINACS)
- Compact Advance Radiotherapy Systems
- Tomotherapy
- Proton Therapy System
- Cyclotrons
- Synchrotrons
- Internal Radiation Therapy
- Seeds
- Applicators and Afterloaders
- External Brachytherapy
- Systemic Radiotherapy
- Cumbersome Regulatory Requirements
- Alpha Emitters
- Beta Emitters
Chapter 5: Market Breakdown by Technology
- External Radiotherapy Market by Technology
- Particle Therapy/Proton Beam Therapy
- Stereotactic Radiosurgery (SRS) and Fractionated Stereotactic Radiation Therapy
- Image-guided Radiation Therapy (IGRT)
- Intensity-modulated Radiation Therapy (IMRT)
- Three-dimensional Conformal Radiation Therapy (3D-CRT)
- Volumetric Modulated Arc Therapy (VMAT)
- Internal Radiotherapy by Technology
- PDR Brachytherapy
- Low Dose Rate Brachytherapy
- High Dose Rate Brachytherapy
- Systemic Radiotherapy by Technology
- Comparison Between Alpha and Beta Emitters
Chapter 6: Market Breakdown by Application
- External Beam Radiation Therapy Market
- Prostate Cancer
- Breast Cancer
- Lung Cancer
- Head and Neck Cancer
- Other Cancers
- Internal Radiation Therapy Market by Application
- Prostate Cancer
- Head and Neck Cancer
- Gynecological Cancer
- Breast Cancer
- Cervical Cancer
- Systemic Radiation Therapy
- Hyperthyroidism
- Bone Metastases
- Lymphoma
- Endocrine Tumors
Chapter 7: Market Breakdown by Region
Chapter 8: Competitive Landscape
- New Products Launches and Product Enhancement
- Agreement, Partnerships, Collaboration and Contract Approvals
- Mergers and Acquisitions
- Other Developments
Chapter 9: Company Profiles
- Accuray (U.S.).
- Elekta (Sweden)
- IBA-Worldwide Proton Therapy (Belgium)
- Varian (U.S)
For more information about this report visit https://www.researchandmarkets.com/research/b86cdf/radiotherapy
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article